Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Individualized Versus Non-Individualized Resistance Training

5 ноября 2026 г. обновлено: Christophe Delecluse, Universitaire Ziekenhuizen KU Leuven

Индивидуальное вмешательство для предотвращения возрастного снижения мышечной силы и функциональных способностей

Preserving functional ability is crucial for healthy aging. Unfortunately, age-related decreases in muscle power often lead to declines in functional ability. As power is the product of force and velocity, decreases in power can originate from changes in muscle force, contraction velocity, or both, varying between individuals. The primary method to prevent functional disability is power-based resistance training. Although training interventions are effective for most older adults, they do not induce substantial improvements in a subset of the population. These inconsistent outcomes may arise from neglecting the observed differences in the force-velocity (F-V) profiles between individuals. Therefore, this study provides a novel approach to resistance exercise, in which exercise dose is tailored according to the individual's F-V profile. The effectiveness of the tailored method will be assessed in a randomized control trial, comparing the effects of an individualized and a non-individualized 12-week training intervention on muscle power parameters and functional ability.

Обзор исследования

Статус

Завершенный

Тип исследования

Интервенционный

Регистрация (Действительный)

80

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Бельгия, 3000
        • KU Leuven - Department of Movement Sciences

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

65 лет и старше (Пожилой взрослый)

Принимает здоровых добровольцев

Да

Полы, имеющие право на обучение

Все

Описание

Inclusion Criteria:

  • Community-dwelling adults
  • At least 65 years old

Exclusion Criteria:

  • Systematic engagement in resistance exercise during the past year
  • Unstable cardiovascular disease, neuromuscular disease, acute infection or fever
  • Recent surgery
  • Lower-extremity injuries
  • Low levels of functional ability (i.e., SPPB score ≤ 9)
  • Cognitive malfunctioning (i.e., Mini-Mental State Examination < 24)

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Профилактика
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Нет (открытая этикетка)

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Individualized resistance exercise program

Individualized exercise dose. All individuals perform resistance exercises at a load that targets their deficit. Individuals with a velocity deficit train at low loads while individuals with a force deficit train at high loads.

2x/week, 35-45 min sessions, on leg press machine

Активный компаратор: Non-individualized resistance exercise program

Non-individualized exercise dose. All individuals perform resistance exercises at a load that does not target their deficit. Individuals with a velocity deficit train at high loads while individuals with a force deficit train at low loads.

2x/week, 35-45 min sessions, on leg press machine

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Maximal power (Pmax)
Временное ограничение: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the maximal power (Pmax; W) was estimated.

Change from baseline at 6 and 12 weeks
Maximal isometric force (F0)
Временное ограничение: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal isometric force (F0; N) was estimated.

Change from baseline at 6 and 12 weeks
Maximal unloaded velocity (V0)
Временное ограничение: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal unloaded velocity (V0; m/s) was estimated.

Change from baseline at 6 and 12 weeks
Force-velocity slope
Временное ограничение: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the F-V slope (Ns/m) was derived.

Change from baseline at 6 and 12 weeks

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Short Physical Performance Battery (SPPB)
Временное ограничение: Score at baseline

Total score on the SPPB (min 0, max 12, higher scores indicate better performance)

Score at baseline
Hand grip strength
Временное ограничение: Change from baseline at 6 and 12 weeks

Maximal grip strength (kg) of the dominant hand using an isometric dynamometer adjusted for hand size

Change from baseline at 6 and 12 weeks
Maximal gait speed
Временное ограничение: Change from baseline at 6 and 12 weeks

The average time (s) to walk 10m as fast as possible

Change from baseline at 6 and 12 weeks
Countermovement jump
Временное ограничение: Change from baseline at 6 and 12 weeks

The jump height (mm) in a countermovement jump

Change from baseline at 6 and 12 weeks
Timed up-and-go
Временное ограничение: Change from baseline at 6 and 12 weeks

The time (s) needed to stand up from a chair, walk 3 m, turn, walk back and sit down again as fast as possible

Change from baseline at 6 and 12 weeks
5-repetition sit-to-stand time
Временное ограничение: Change from baseline at 6 and 12 weeks

The time (s) needed to complete the 5-repetition sit-to-stand test

Change from baseline at 6 and 12 weeks
5-repetition sit-to-stand power
Временное ограничение: Change from baseline at 6 and 12 weeks

The average power (watt) produced during the 5-repetition sit-to-stand test

Change from baseline at 6 and 12 weeks
30-second sit-to-stand repetitions
Временное ограничение: Change from baseline at 6 and 12 weeks

The number of repetitions completed during the 30-second sit-to-stand test

Change from baseline at 6 and 12 weeks
30-second sit-to-stand power
Временное ограничение: Change from baseline at 6 and 12 weeks

The average power (watt) produced during the 30-second sit-to-stand test

Change from baseline at 6 and 12 weeks
Stair ascent time
Временное ограничение: Change from baseline at 6 and 12 weeks

The time (s) needed to ascend a flight of stairs

Change from baseline at 6 and 12 weeks
Stair ascent power
Временное ограничение: Change from baseline at 6 and 12 weeks

The average power (Watt) produced during the stair ascent test

Change from baseline at 6 and 12 weeks
Exercise adherence
Временное ограничение: Total adherence over 12-week period

Number of sessions attended as a percentage of total sessions planned

Total adherence over 12-week period
Absolute training load
Временное ограничение: Consistently recorded throughout the 12-week intervention

The absolute load (kg) used during training sessions

Consistently recorded throughout the 12-week intervention
Relative training load
Временное ограничение: Consistently recorded throughout the 12-week intervention

The relative load (%1RM) used during training sessions

Consistently recorded throughout the 12-week intervention
Number of repetitions
Временное ограничение: Consistently recorded throughout the 12-week intervention

The number of repetitions (n) completed per set

Consistently recorded throughout the 12-week intervention
Highest movement velocity within a set
Временное ограничение: Consistently recorded throughout the 12-week intervention

The velocity (m/s) of the fastest repetition in a set (Vmax)

Consistently recorded throughout the 12-week intervention
Lowest movement velocity within a set
Временное ограничение: Consistently recorded throughout the 12-week intervention

The velocity (m/s) of the slowest repetition in a set (Vmin)

Consistently recorded throughout the 12-week intervention
Velocity loss
Временное ограничение: Consistently recorded throughout the 12-week intervention

The percentage difference between the highest and lowest movement velocity in a set = ([Vmax - Vmin] / Vmax) × 100

Consistently recorded throughout the 12-week intervention
Set-volume index
Временное ограничение: Consistently recorded throughout the 12-week intervention

The number of repetitions × relative load (%1-RM) per set

Consistently recorded throughout the 12-week intervention
Session-volume index
Временное ограничение: Consistently recorded throughout the 12-week intervention

The sum of set volumes per session

Consistently recorded throughout the 12-week intervention

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Публикации и полезные ссылки

Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

20 мая 2024 г.

Первичное завершение (Действительный)

4 декабря 2025 г.

Завершение исследования (Действительный)

4 декабря 2025 г.

Даты регистрации исследования

Первый отправленный

5 марта 2024 г.

Впервые представлено, что соответствует критериям контроля качества

5 июня 2024 г.

Первый опубликованный (Действительный)

10 июня 2024 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

6 ноября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

5 ноября 2026 г.

Последняя проверка

1 ноября 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Другие идентификационные номера исследования

  • S68434

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться